Regeneron's bid to acquire the bankrupt genetic testing firm 23andMe for $256 million has likely come to an end.

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

Anne Wojcicki’s nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing ...

A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court ...

Previous reports (including ours) said that a company named Regeneron was supposed to be the buyer, but that deal ended up ...

Anne Wojcicki's TTAM Research Institute has received court approval to acquire 23andMe, the genetic testing company she ...

23andMe has said it wants to allow new bids by both parties with a deadline of 12th June, according to a Financial Times report, which suggested Regeneron may get the option to make a counter ...

A federal bankruptcy court this week approved the sale of 23andMe to TTAM Research Institute - a new company launched by ...